REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery
NCT ID: NCT02073162
Last Updated: 2019-10-31
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3000 participants
INTERVENTIONAL
2014-02-28
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Those who take part in the study will be visited five times before and after surgery in the hospital. Once discharged from the hospital, participants will be called 4 times on the telephone.
Preadmission Clinic/Preoperative Visit
* Sign the consent document
* Have blood drawn for standard preoperative tests (standard of care)
* Have an electrocardiogram (standard of care)
* Complete a questionnaire on disability (research)
Day of Surgery
* Have blood drawn if not already done during the first visit (standard of care)
* Have an electrocardiogram if not already done during the first visit (standard of care)
* Be randomly assigned to either restrictive or liberal fluid management (research)
Post-op Day 1
* Have an electrocardiogram done (research)
* Have blood drawn for standard tests (standard of care)
* Have a wound inspection, if there is a change of dressing (standard of care)
* Complete a questionnaire about your recovery (research)
Post-op Day 3
* Have blood drawn for standard tests (standard of care) and c-reactive protein, which can indicate infection (for research).
* Have a wound inspection, if there is a change of dressing (standard of care)
* Complete a questionnaire about your recovery (research)
Day of Discharge
* Have a wound inspection, if there is a change of dressing (standard of care)
30-Day Follow-up Phone Call
* Complete a questionnaire about your recovery (research)
* Complete a questionnaire about disability (research)
3 Month, 6-Month, and 12-Month Follow-up Phone Calls
* Complete a questionnaire about disability (research)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery: RELIEF Study
NCT01424150
Restricted Fluid Regimen in Open Abdominal Bowel Surgery
NCT00456703
The Effect of Intraoperative Goal Directed Restricted Fluid Therapy on Extravascular Lung Water
NCT02845310
Intraoperative Hypovolemia and Fluid Therapy
NCT00852449
Restrictive vs Goal Directed Fluid Therapy During Hepatobiliary Surgery
NCT04092608
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liberal group
At induction-Hartmanns 10 ml/kg During surgery-Hartmanns 8 ml/kg/h After surgery-IV fluids ≥1.5 ml/kg/h Continue IV fluids ≥24hrs
Major Abdominal Surgery
•All types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days (for example, oesophagectomy, gastrectomy, pancreatectomy, colectomy, aortic or aorto-femoral vascular surgery, nephrectomy, cystectomy, open prostatectomy, radical hysterectomy, and abdominal incisional hernia repair)
Restrictive group
At induction-Hartmanns ≤5 ml/kg During surgery-Hartmanns 5 ml/kg/h After surgery-IV fluids, ≤0.8 ml/kg/h Cease IV fluids ASAP,aim for early oral fluids
Major Abdominal Surgery
•All types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days (for example, oesophagectomy, gastrectomy, pancreatectomy, colectomy, aortic or aorto-femoral vascular surgery, nephrectomy, cystectomy, open prostatectomy, radical hysterectomy, and abdominal incisional hernia repair)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Major Abdominal Surgery
•All types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days (for example, oesophagectomy, gastrectomy, pancreatectomy, colectomy, aortic or aorto-femoral vascular surgery, nephrectomy, cystectomy, open prostatectomy, radical hysterectomy, and abdominal incisional hernia repair)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* all types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days (for example, oesophagectomy, gastrectomy, pancreatectomy, colectomy, aortic or aorto-femoral vascular surgery, nephrectomy, cystectomy, open prostatectomy, radical hysterectomy, and abdominal incisional hernia repair)
* at increased risk of postoperative complications, defined as at least one of the following criteria:
* age ≥70 years
* known or documented history of coronary artery disease
* known or documented history of heart failure
* diabetes currently treated with an oral hypoglycaemic agent and/or insulin
* preoperative serum creatinine \>200 μmol/L (\>2.8 mg/dl)
* morbid obesity (BMI ≥35 kg/m2)
* preoperative serum albumin \<30 g/L
* anaerobic threshold (if done) \<12 mL/kg/min
* or two or more of the following risk factors:
* ASA 3 or 4
* chronic respiratory disease
* obesity (BMI 30-35 kg/m2)
* aortic or peripheral vascular disease
* preoperative haemoglobin \<100 g/L
* preoperative serum creatinine 150-199 μmol/L (\>1.7 mg/dl)
* anaerobic threshold (if done) 12-14 mL/kg/min
Exclusion Criteria
* ASA physical status 5 - such patients are not expected to survive with or without surgery, and their underlying illness is expected to have an overwhelming effect on outcome (irrespective of fluid therapy)
* chronic renal failure requiring dialysis
* pulmonary or cardiac surgery - different pathophysiology, and thoracic surgery typically have strict fluid restrictions
* liver resection - most units have strict fluid/CVP limits in place and won't allow randomisation
* minor or intermediate surgery, such as laparoscopic cholecystectomy, transurethral resection of the prostate, inguinal hernia repair, splenectomy, closure of colostomy - each of these are typically "minor" surgery with minimal IV fluid requirements, generally low rates of complications and mostly very good survival.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea Kurz
Role: PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-1287
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.